JP2004500802A - ピロコッカス・アビシのゲノム配列およびポリペプチド、そのフラグメントおよびその使用 - Google Patents
ピロコッカス・アビシのゲノム配列およびポリペプチド、そのフラグメントおよびその使用 Download PDFInfo
- Publication number
- JP2004500802A JP2004500802A JP2000614397A JP2000614397A JP2004500802A JP 2004500802 A JP2004500802 A JP 2004500802A JP 2000614397 A JP2000614397 A JP 2000614397A JP 2000614397 A JP2000614397 A JP 2000614397A JP 2004500802 A JP2004500802 A JP 2004500802A
- Authority
- JP
- Japan
- Prior art keywords
- polypeptide
- sequence
- nucleotide sequence
- seq
- fragments
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 108090000765 processed proteins & peptides Proteins 0.000 title claims abstract description 288
- 229920001184 polypeptide Polymers 0.000 title claims abstract description 282
- 102000004196 processed proteins & peptides Human genes 0.000 title claims abstract description 282
- 241001148023 Pyrococcus abyssi Species 0.000 title claims abstract description 97
- 239000012634 fragment Substances 0.000 title claims description 214
- 125000003729 nucleotide group Chemical group 0.000 claims abstract description 216
- 239000002773 nucleotide Substances 0.000 claims abstract description 213
- 238000000034 method Methods 0.000 claims abstract description 66
- 239000013598 vector Substances 0.000 claims abstract description 50
- 230000010076 replication Effects 0.000 claims abstract description 35
- 150000007523 nucleic acids Chemical class 0.000 claims abstract description 27
- 230000015572 biosynthetic process Effects 0.000 claims abstract description 25
- 102000039446 nucleic acids Human genes 0.000 claims abstract description 24
- 108020004707 nucleic acids Proteins 0.000 claims abstract description 24
- 238000006065 biodegradation reaction Methods 0.000 claims abstract description 9
- 230000000694 effects Effects 0.000 claims description 139
- 108090000623 proteins and genes Proteins 0.000 claims description 100
- 210000004027 cell Anatomy 0.000 claims description 80
- 108020004414 DNA Proteins 0.000 claims description 67
- 102000004169 proteins and genes Human genes 0.000 claims description 46
- 238000006243 chemical reaction Methods 0.000 claims description 45
- 150000001413 amino acids Chemical class 0.000 claims description 41
- 102000016928 DNA-directed DNA polymerase Human genes 0.000 claims description 40
- 108010014303 DNA-directed DNA polymerase Proteins 0.000 claims description 40
- 238000003199 nucleic acid amplification method Methods 0.000 claims description 32
- 108091028043 Nucleic acid sequence Proteins 0.000 claims description 29
- 230000017730 intein-mediated protein splicing Effects 0.000 claims description 28
- 230000004060 metabolic process Effects 0.000 claims description 28
- 230000003321 amplification Effects 0.000 claims description 27
- 239000013604 expression vector Substances 0.000 claims description 19
- 230000032258 transport Effects 0.000 claims description 19
- 241001465754 Metazoa Species 0.000 claims description 17
- 230000008439 repair process Effects 0.000 claims description 15
- 241000205160 Pyrococcus Species 0.000 claims description 14
- 108090000626 DNA-directed RNA polymerases Proteins 0.000 claims description 13
- 102000004163 DNA-directed RNA polymerases Human genes 0.000 claims description 13
- 230000006798 recombination Effects 0.000 claims description 13
- 239000000523 sample Substances 0.000 claims description 13
- 238000013518 transcription Methods 0.000 claims description 12
- 230000035897 transcription Effects 0.000 claims description 12
- 108091005804 Peptidases Proteins 0.000 claims description 11
- 230000000295 complement effect Effects 0.000 claims description 11
- 238000006116 polymerization reaction Methods 0.000 claims description 11
- 238000005215 recombination Methods 0.000 claims description 11
- 230000028327 secretion Effects 0.000 claims description 9
- 102000019040 Nuclear Antigens Human genes 0.000 claims description 8
- 108010051791 Nuclear Antigens Proteins 0.000 claims description 8
- 239000012472 biological sample Substances 0.000 claims description 8
- 238000001514 detection method Methods 0.000 claims description 8
- 241000432808 Pyrococcus abyssi GE5 Species 0.000 claims description 7
- 230000004663 cell proliferation Effects 0.000 claims description 7
- 230000035772 mutation Effects 0.000 claims description 7
- 235000000346 sugar Nutrition 0.000 claims description 7
- 238000013519 translation Methods 0.000 claims description 7
- 102000003960 Ligases Human genes 0.000 claims description 6
- 108090000364 Ligases Proteins 0.000 claims description 6
- 102000004317 Lyases Human genes 0.000 claims description 6
- 108090000856 Lyases Proteins 0.000 claims description 6
- -1 ORF545 Proteins 0.000 claims description 6
- 102000002508 Peptide Elongation Factors Human genes 0.000 claims description 6
- 108010068204 Peptide Elongation Factors Proteins 0.000 claims description 6
- 102000004160 Phosphoric Monoester Hydrolases Human genes 0.000 claims description 6
- 108090000608 Phosphoric Monoester Hydrolases Proteins 0.000 claims description 6
- 239000004365 Protease Substances 0.000 claims description 6
- 108091023040 Transcription factor Proteins 0.000 claims description 6
- 102000040945 Transcription factor Human genes 0.000 claims description 6
- 102000004357 Transferases Human genes 0.000 claims description 6
- 108090000992 Transferases Proteins 0.000 claims description 6
- 239000005515 coenzyme Substances 0.000 claims description 6
- 229910001410 inorganic ion Inorganic materials 0.000 claims description 6
- 239000012528 membrane Substances 0.000 claims description 6
- 230000004899 motility Effects 0.000 claims description 6
- 101000768938 Haemophilus phage HP1 (strain HP1c1) Uncharacterized 8.9 kDa protein in int-C1 intergenic region Proteins 0.000 claims description 5
- 101710125507 Integrase/recombinase Proteins 0.000 claims description 5
- 108090000769 Isomerases Proteins 0.000 claims description 5
- 102000004195 Isomerases Human genes 0.000 claims description 5
- 101710159752 Poly(3-hydroxyalkanoate) polymerase subunit PhaE Proteins 0.000 claims description 5
- 101710130262 Probable Vpr-like protein Proteins 0.000 claims description 5
- 239000003153 chemical reaction reagent Substances 0.000 claims description 5
- 230000009466 transformation Effects 0.000 claims description 5
- 108020004635 Complementary DNA Proteins 0.000 claims description 4
- 102000004157 Hydrolases Human genes 0.000 claims description 4
- 108090000604 Hydrolases Proteins 0.000 claims description 4
- 230000023852 carbohydrate metabolic process Effects 0.000 claims description 4
- 235000021256 carbohydrate metabolism Nutrition 0.000 claims description 4
- 150000001875 compounds Chemical class 0.000 claims description 4
- 101000956733 Arabidopsis thaliana Uncharacterized mitochondrial protein AtMg01050 Proteins 0.000 claims description 3
- 101100214868 Autographa californica nuclear polyhedrosis virus AC54 gene Proteins 0.000 claims description 3
- 101000736076 Bacillus subtilis (strain 168) Uncharacterized protein YcbR Proteins 0.000 claims description 3
- 101000792448 Chlorella vulgaris Uncharacterized 79.7 kDa protein in psaB-ycf62 intergenic region Proteins 0.000 claims description 3
- 101100064352 Human herpesvirus 8 type P (isolate GK18) DUT gene Proteins 0.000 claims description 3
- 101000957786 Klebsiella pneumoniae Phosphomannomutase Proteins 0.000 claims description 3
- 101150098690 ORF54 gene Proteins 0.000 claims description 3
- 101100306237 Orgyia pseudotsugata multicapsid polyhedrosis virus LEF-8 gene Proteins 0.000 claims description 3
- 239000003054 catalyst Substances 0.000 claims description 3
- 230000037356 lipid metabolism Effects 0.000 claims description 3
- 230000004260 plant-type cell wall biogenesis Effects 0.000 claims description 3
- 101000958449 Arabidopsis thaliana Uncharacterized mitochondrial protein AtMg00310 Proteins 0.000 claims description 2
- 101100074342 Autographa californica nuclear polyhedrosis virus LEF-11 gene Proteins 0.000 claims description 2
- 101000963888 Dictyostelium citrinum Uncharacterized mitochondrial protein Mp36 Proteins 0.000 claims description 2
- 102100024101 DnaJ homolog subfamily C member 28 Human genes 0.000 claims description 2
- 101000764195 Euglena longa Uncharacterized 51.9 kDa protein in rps4-rps11 intergenic region Proteins 0.000 claims description 2
- 101000764374 Euglena longa Uncharacterized 66.5 kDa protein in trnI-trnV intergenic region Proteins 0.000 claims description 2
- 101000626971 Guillardia theta Uncharacterized 8.1 kDa protein Proteins 0.000 claims description 2
- 101000933958 Haemophilus phage HP1 (strain HP1c1) Major capsid protein Proteins 0.000 claims description 2
- 101000758963 Haemophilus phage HP1 (strain HP1c1) Uncharacterized 12.7 kDa protein in lys 3'region Proteins 0.000 claims description 2
- 101000977016 Haemophilus phage HP1 (strain HP1c1) Uncharacterized 8.9 kDa protein in int-C1 intergenic region Proteins 0.000 claims description 2
- 101001053999 Homo sapiens DnaJ homolog subfamily C member 28 Proteins 0.000 claims description 2
- 101000790837 Klebsiella pneumoniae Uncharacterized 18.9 kDa protein in cps region Proteins 0.000 claims description 2
- 101000708517 Marchantia polymorpha Uncharacterized mitochondrial protein ymf13 Proteins 0.000 claims description 2
- 101150020791 ORF37 gene Proteins 0.000 claims description 2
- 101150075249 ORF40 gene Proteins 0.000 claims description 2
- 101150092861 ORF71 gene Proteins 0.000 claims description 2
- 101100156835 Paenarthrobacter nicotinovorans xdh gene Proteins 0.000 claims description 2
- 101000764206 Porphyra purpurea Uncharacterized protein in rpl9-rpl11 intergenic region Proteins 0.000 claims description 2
- 101000585887 Streptomyces ambofaciens MutT-like protein Proteins 0.000 claims description 2
- 101000764666 Trieres chinensis UPF0051 protein ycf24 Proteins 0.000 claims description 2
- 101000792500 Trieres chinensis Uncharacterized protein ycf88 Proteins 0.000 claims description 2
- 108091008324 binding proteins Proteins 0.000 claims description 2
- 239000013599 cloning vector Substances 0.000 claims description 2
- 101150055782 gH gene Proteins 0.000 claims description 2
- 230000037360 nucleotide metabolism Effects 0.000 claims 2
- 101100318332 Acidianus bottle-shaped virus (isolate Italy/Pozzuoli) ORF174 gene Proteins 0.000 claims 1
- 101100059051 Acidianus filamentous virus 1 (isolate United States/Yellowstone) ORF132 gene Proteins 0.000 claims 1
- 101000979022 Arabidopsis thaliana Uncharacterized mitochondrial cytochrome b-like protein AtMg00590 Proteins 0.000 claims 1
- 101000958431 Arabidopsis thaliana Uncharacterized mitochondrial protein AtMg00320 Proteins 0.000 claims 1
- 101100214860 Autographa californica nuclear polyhedrosis virus Ac132 gene Proteins 0.000 claims 1
- 101100135329 Autographa californica nuclear polyhedrosis virus P6.9 gene Proteins 0.000 claims 1
- 101000756436 Autographa californica nuclear polyhedrosis virus Uncharacterized 23.6 kDa protein in LEF2-PH intergenic region Proteins 0.000 claims 1
- 101000626902 Chlorella vulgaris Uncharacterized 28.3 kDa protein in rrn23-psbC intergenic region Proteins 0.000 claims 1
- 101000624609 Dictyostelium discoideum Uncharacterized mitochondrial protein 35 Proteins 0.000 claims 1
- 101000626915 Euglena longa Uncharacterized protein in rps2-rps9 intergenic region Proteins 0.000 claims 1
- 101000854890 Haemophilus phage HP1 (strain HP1c1) Probable terminase, ATPase subunit Proteins 0.000 claims 1
- 101000768945 Haemophilus phage HP1 (strain HP1c1) Uncharacterized 7.9 kDa protein in int-C1 intergenic region Proteins 0.000 claims 1
- 101100283436 Human herpesvirus 8 type P (isolate GK18) gM gene Proteins 0.000 claims 1
- 101000578717 Klebsiella pneumoniae Mannose-1-phosphate guanylyltransferase Proteins 0.000 claims 1
- 108010006519 Molecular Chaperones Proteins 0.000 claims 1
- 102000005431 Molecular Chaperones Human genes 0.000 claims 1
- 101100289047 Novosphingobium sp. (strain KA1) ligU gene Proteins 0.000 claims 1
- 101150016564 ORF39 gene Proteins 0.000 claims 1
- 101100181496 Orgyia pseudotsugata multicapsid polyhedrosis virus LEF-5 gene Proteins 0.000 claims 1
- 101100083931 Orgyia pseudotsugata multicapsid polyhedrosis virus P26 gene Proteins 0.000 claims 1
- 101100064055 Ostreid herpesvirus 1 (isolate France) ORF100 gene Proteins 0.000 claims 1
- 101100378791 Paenarthrobacter nicotinovorans aldh gene Proteins 0.000 claims 1
- 102100037486 Reverse transcriptase/ribonuclease H Human genes 0.000 claims 1
- 125000003275 alpha amino acid group Chemical group 0.000 claims 1
- 102000023732 binding proteins Human genes 0.000 claims 1
- 230000033001 locomotion Effects 0.000 claims 1
- 244000000010 microbial pathogen Species 0.000 claims 1
- 230000008569 process Effects 0.000 abstract description 16
- 230000002503 metabolic effect Effects 0.000 abstract description 2
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 42
- 235000018102 proteins Nutrition 0.000 description 40
- 230000014509 gene expression Effects 0.000 description 34
- 241000588724 Escherichia coli Species 0.000 description 30
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 28
- 239000002609 medium Substances 0.000 description 27
- 235000001014 amino acid Nutrition 0.000 description 26
- 229940024606 amino acid Drugs 0.000 description 26
- 239000000872 buffer Substances 0.000 description 26
- 238000010367 cloning Methods 0.000 description 26
- 238000012163 sequencing technique Methods 0.000 description 24
- 102000004594 DNA Polymerase I Human genes 0.000 description 23
- 102000004190 Enzymes Human genes 0.000 description 21
- 108090000790 Enzymes Proteins 0.000 description 21
- 229940088598 enzyme Drugs 0.000 description 21
- 101100278439 Archaeoglobus fulgidus (strain ATCC 49558 / DSM 4304 / JCM 9628 / NBRC 100126 / VC-16) pol gene Proteins 0.000 description 20
- 102000010567 DNA Polymerase II Human genes 0.000 description 20
- 101150005648 polB gene Proteins 0.000 description 20
- QKNYBSVHEMOAJP-UHFFFAOYSA-N 2-amino-2-(hydroxymethyl)propane-1,3-diol;hydron;chloride Chemical compound Cl.OCC(N)(CO)CO QKNYBSVHEMOAJP-UHFFFAOYSA-N 0.000 description 18
- 108010017826 DNA Polymerase I Proteins 0.000 description 18
- 108010063113 DNA Polymerase II Proteins 0.000 description 18
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 18
- BPHPUYQFMNQIOC-NXRLNHOXSA-N isopropyl beta-D-thiogalactopyranoside Chemical compound CC(C)S[C@@H]1O[C@H](CO)[C@H](O)[C@H](O)[C@H]1O BPHPUYQFMNQIOC-NXRLNHOXSA-N 0.000 description 18
- 101150008507 dnaE gene Proteins 0.000 description 17
- 101150060505 polC gene Proteins 0.000 description 17
- 239000011780 sodium chloride Substances 0.000 description 14
- 101150076840 PolI gene Proteins 0.000 description 13
- NHVNXKFIZYSCEB-XLPZGREQSA-N dTTP Chemical compound O=C1NC(=O)C(C)=CN1[C@@H]1O[C@H](COP(O)(=O)OP(O)(=O)OP(O)(O)=O)[C@@H](O)C1 NHVNXKFIZYSCEB-XLPZGREQSA-N 0.000 description 13
- 239000013612 plasmid Substances 0.000 description 13
- HEDRZPFGACZZDS-UHFFFAOYSA-N Chloroform Chemical compound ClC(Cl)Cl HEDRZPFGACZZDS-UHFFFAOYSA-N 0.000 description 12
- SUYVUBYJARFZHO-RRKCRQDMSA-N dATP Chemical compound C1=NC=2C(N)=NC=NC=2N1[C@H]1C[C@H](O)[C@@H](COP(O)(=O)OP(O)(=O)OP(O)(O)=O)O1 SUYVUBYJARFZHO-RRKCRQDMSA-N 0.000 description 12
- SUYVUBYJARFZHO-UHFFFAOYSA-N dATP Natural products C1=NC=2C(N)=NC=NC=2N1C1CC(O)C(COP(O)(=O)OP(O)(=O)OP(O)(O)=O)O1 SUYVUBYJARFZHO-UHFFFAOYSA-N 0.000 description 12
- HAAZLUGHYHWQIW-KVQBGUIXSA-N dGTP Chemical compound C1=NC=2C(=O)NC(N)=NC=2N1[C@H]1C[C@H](O)[C@@H](COP(O)(=O)OP(O)(=O)OP(O)(O)=O)O1 HAAZLUGHYHWQIW-KVQBGUIXSA-N 0.000 description 12
- 238000005516 engineering process Methods 0.000 description 12
- 230000001965 increasing effect Effects 0.000 description 12
- 238000004519 manufacturing process Methods 0.000 description 12
- 238000003786 synthesis reaction Methods 0.000 description 12
- RGWHQCVHVJXOKC-SHYZEUOFSA-J dCTP(4-) Chemical compound O=C1N=C(N)C=CN1[C@@H]1O[C@H](COP([O-])(=O)OP([O-])(=O)OP([O-])([O-])=O)[C@@H](O)C1 RGWHQCVHVJXOKC-SHYZEUOFSA-J 0.000 description 11
- 239000011541 reaction mixture Substances 0.000 description 11
- 102000035195 Peptidases Human genes 0.000 description 10
- 239000001888 Peptone Substances 0.000 description 10
- 108010080698 Peptones Proteins 0.000 description 10
- ISWSIDIOOBJBQZ-UHFFFAOYSA-N Phenol Chemical compound OC1=CC=CC=C1 ISWSIDIOOBJBQZ-UHFFFAOYSA-N 0.000 description 10
- 229940041514 candida albicans extract Drugs 0.000 description 10
- 238000005119 centrifugation Methods 0.000 description 10
- 230000006698 induction Effects 0.000 description 10
- 239000000203 mixture Substances 0.000 description 10
- 235000019319 peptone Nutrition 0.000 description 10
- 238000000746 purification Methods 0.000 description 10
- 241000894007 species Species 0.000 description 10
- 230000009261 transgenic effect Effects 0.000 description 10
- 238000005406 washing Methods 0.000 description 10
- 239000012138 yeast extract Substances 0.000 description 10
- 241000203069 Archaea Species 0.000 description 9
- 238000000338 in vitro Methods 0.000 description 9
- 239000012429 reaction media Substances 0.000 description 9
- 238000006467 substitution reaction Methods 0.000 description 9
- 230000006870 function Effects 0.000 description 8
- 238000009396 hybridization Methods 0.000 description 8
- 239000011159 matrix material Substances 0.000 description 8
- 239000000047 product Substances 0.000 description 8
- 229920000936 Agarose Polymers 0.000 description 7
- 241000894006 Bacteria Species 0.000 description 7
- 230000004543 DNA replication Effects 0.000 description 7
- 108010002747 Pfu DNA polymerase Proteins 0.000 description 7
- 108020004511 Recombinant DNA Proteins 0.000 description 7
- 238000000605 extraction Methods 0.000 description 7
- 239000000499 gel Substances 0.000 description 7
- 230000010354 integration Effects 0.000 description 7
- 230000035939 shock Effects 0.000 description 7
- FQENQNTWSFEDLI-UHFFFAOYSA-J sodium diphosphate Chemical compound [Na+].[Na+].[Na+].[Na+].[O-]P([O-])(=O)OP([O-])([O-])=O FQENQNTWSFEDLI-UHFFFAOYSA-J 0.000 description 7
- 229940048086 sodium pyrophosphate Drugs 0.000 description 7
- 235000019818 tetrasodium diphosphate Nutrition 0.000 description 7
- 239000001577 tetrasodium phosphonato phosphate Substances 0.000 description 7
- DGVVWUTYPXICAM-UHFFFAOYSA-N β‐Mercaptoethanol Chemical compound OCCS DGVVWUTYPXICAM-UHFFFAOYSA-N 0.000 description 7
- 101100010182 Pyrococcus abyssi (strain GE5 / Orsay) polB gene Proteins 0.000 description 6
- 102000018779 Replication Protein C Human genes 0.000 description 6
- 108010027647 Replication Protein C Proteins 0.000 description 6
- 238000001035 drying Methods 0.000 description 6
- 108091008146 restriction endonucleases Proteins 0.000 description 6
- 239000000243 solution Substances 0.000 description 6
- KCXVZYZYPLLWCC-UHFFFAOYSA-N EDTA Chemical compound OC(=O)CN(CC(O)=O)CCN(CC(O)=O)CC(O)=O KCXVZYZYPLLWCC-UHFFFAOYSA-N 0.000 description 5
- 241001288713 Escherichia coli MC1061 Species 0.000 description 5
- 108091034117 Oligonucleotide Proteins 0.000 description 5
- 238000007792 addition Methods 0.000 description 5
- 230000004186 co-expression Effects 0.000 description 5
- 238000012217 deletion Methods 0.000 description 5
- 230000037430 deletion Effects 0.000 description 5
- VHJLVAABSRFDPM-QWWZWVQMSA-N dithiothreitol Chemical compound SC[C@@H](O)[C@H](O)CS VHJLVAABSRFDPM-QWWZWVQMSA-N 0.000 description 5
- 238000001962 electrophoresis Methods 0.000 description 5
- 239000000284 extract Substances 0.000 description 5
- 230000002068 genetic effect Effects 0.000 description 5
- 150000002484 inorganic compounds Chemical class 0.000 description 5
- 229910010272 inorganic material Inorganic materials 0.000 description 5
- 229930027917 kanamycin Natural products 0.000 description 5
- 229960000318 kanamycin Drugs 0.000 description 5
- SBUJHOSQTJFQJX-NOAMYHISSA-N kanamycin Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CN)O[C@@H]1O[C@H]1[C@H](O)[C@@H](O[C@@H]2[C@@H]([C@@H](N)[C@H](O)[C@@H](CO)O2)O)[C@H](N)C[C@@H]1N SBUJHOSQTJFQJX-NOAMYHISSA-N 0.000 description 5
- 229930182823 kanamycin A Natural products 0.000 description 5
- 238000005259 measurement Methods 0.000 description 5
- 244000005700 microbiome Species 0.000 description 5
- 230000004048 modification Effects 0.000 description 5
- 238000012986 modification Methods 0.000 description 5
- 150000002894 organic compounds Chemical class 0.000 description 5
- 238000002415 sodium dodecyl sulfate polyacrylamide gel electrophoresis Methods 0.000 description 5
- 230000014616 translation Effects 0.000 description 5
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Chemical compound O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 5
- 102000053602 DNA Human genes 0.000 description 4
- 230000004544 DNA amplification Effects 0.000 description 4
- TWRXJAOTZQYOKJ-UHFFFAOYSA-L Magnesium chloride Chemical compound [Mg+2].[Cl-].[Cl-] TWRXJAOTZQYOKJ-UHFFFAOYSA-L 0.000 description 4
- 101100010170 Pyrococcus abyssi (strain GE5 / Orsay) polC gene Proteins 0.000 description 4
- NINIDFKCEFEMDL-UHFFFAOYSA-N Sulfur Chemical compound [S] NINIDFKCEFEMDL-UHFFFAOYSA-N 0.000 description 4
- 239000007983 Tris buffer Substances 0.000 description 4
- JLCPHMBAVCMARE-UHFFFAOYSA-N [3-[[3-[[3-[[3-[[3-[[3-[[3-[[3-[[3-[[3-[[3-[[5-(2-amino-6-oxo-1H-purin-9-yl)-3-[[3-[[3-[[3-[[3-[[3-[[5-(2-amino-6-oxo-1H-purin-9-yl)-3-[[5-(2-amino-6-oxo-1H-purin-9-yl)-3-hydroxyoxolan-2-yl]methoxy-hydroxyphosphoryl]oxyoxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxyoxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methyl [5-(6-aminopurin-9-yl)-2-(hydroxymethyl)oxolan-3-yl] hydrogen phosphate Polymers Cc1cn(C2CC(OP(O)(=O)OCC3OC(CC3OP(O)(=O)OCC3OC(CC3O)n3cnc4c3nc(N)[nH]c4=O)n3cnc4c3nc(N)[nH]c4=O)C(COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3CO)n3cnc4c(N)ncnc34)n3ccc(N)nc3=O)n3cnc4c(N)ncnc34)n3ccc(N)nc3=O)n3ccc(N)nc3=O)n3ccc(N)nc3=O)n3cnc4c(N)ncnc34)n3cnc4c(N)ncnc34)n3cc(C)c(=O)[nH]c3=O)n3cc(C)c(=O)[nH]c3=O)n3ccc(N)nc3=O)n3cc(C)c(=O)[nH]c3=O)n3cnc4c3nc(N)[nH]c4=O)n3cnc4c(N)ncnc34)n3cnc4c(N)ncnc34)n3cnc4c(N)ncnc34)n3cnc4c(N)ncnc34)O2)c(=O)[nH]c1=O JLCPHMBAVCMARE-UHFFFAOYSA-N 0.000 description 4
- 238000004458 analytical method Methods 0.000 description 4
- 230000008901 benefit Effects 0.000 description 4
- 239000000969 carrier Substances 0.000 description 4
- 230000003197 catalytic effect Effects 0.000 description 4
- 125000000524 functional group Chemical group 0.000 description 4
- 238000010353 genetic engineering Methods 0.000 description 4
- 238000003780 insertion Methods 0.000 description 4
- 230000037431 insertion Effects 0.000 description 4
- 238000002844 melting Methods 0.000 description 4
- 230000008018 melting Effects 0.000 description 4
- 238000002360 preparation method Methods 0.000 description 4
- 235000019833 protease Nutrition 0.000 description 4
- 235000019419 proteases Nutrition 0.000 description 4
- 230000001681 protective effect Effects 0.000 description 4
- 150000003839 salts Chemical class 0.000 description 4
- 239000011593 sulfur Substances 0.000 description 4
- 229910052717 sulfur Inorganic materials 0.000 description 4
- LWIHDJKSTIGBAC-UHFFFAOYSA-K tripotassium phosphate Chemical compound [K+].[K+].[K+].[O-]P([O-])([O-])=O LWIHDJKSTIGBAC-UHFFFAOYSA-K 0.000 description 4
- LENZDBCJOHFCAS-UHFFFAOYSA-N tris Chemical compound OCC(N)(CO)CO LENZDBCJOHFCAS-UHFFFAOYSA-N 0.000 description 4
- 241001198387 Escherichia coli BL21(DE3) Species 0.000 description 3
- 241000620209 Escherichia coli DH5[alpha] Species 0.000 description 3
- 241000206602 Eukaryota Species 0.000 description 3
- 108700026244 Open Reading Frames Proteins 0.000 description 3
- 125000000539 amino acid group Chemical group 0.000 description 3
- 230000004071 biological effect Effects 0.000 description 3
- 238000004113 cell culture Methods 0.000 description 3
- 210000002421 cell wall Anatomy 0.000 description 3
- 238000012512 characterization method Methods 0.000 description 3
- 238000004587 chromatography analysis Methods 0.000 description 3
- 210000000349 chromosome Anatomy 0.000 description 3
- 238000012790 confirmation Methods 0.000 description 3
- 238000012258 culturing Methods 0.000 description 3
- 230000001419 dependent effect Effects 0.000 description 3
- 230000029087 digestion Effects 0.000 description 3
- 238000003505 heat denaturation Methods 0.000 description 3
- 230000006872 improvement Effects 0.000 description 3
- 150000002632 lipids Chemical class 0.000 description 3
- 239000012071 phase Substances 0.000 description 3
- 238000003752 polymerase chain reaction Methods 0.000 description 3
- 108091033319 polynucleotide Proteins 0.000 description 3
- 102000040430 polynucleotide Human genes 0.000 description 3
- 239000002157 polynucleotide Substances 0.000 description 3
- 238000011160 research Methods 0.000 description 3
- 239000013049 sediment Substances 0.000 description 3
- 238000010561 standard procedure Methods 0.000 description 3
- 238000001890 transfection Methods 0.000 description 3
- 230000003612 virological effect Effects 0.000 description 3
- 101000768957 Acholeplasma phage L2 Uncharacterized 37.2 kDa protein Proteins 0.000 description 2
- 101000823746 Acidianus ambivalens Uncharacterized 17.7 kDa protein in bps2 3'region Proteins 0.000 description 2
- 101000916369 Acidianus ambivalens Uncharacterized protein in sor 5'region Proteins 0.000 description 2
- 101100487480 Acidianus filamentous virus 1 (isolate United States/Yellowstone) ORF807 gene Proteins 0.000 description 2
- 101000769342 Acinetobacter guillouiae Uncharacterized protein in rpoN-murA intergenic region Proteins 0.000 description 2
- 101000823696 Actinobacillus pleuropneumoniae Uncharacterized glycosyltransferase in aroQ 3'region Proteins 0.000 description 2
- 101000786513 Agrobacterium tumefaciens (strain 15955) Uncharacterized protein outside the virF region Proteins 0.000 description 2
- 101000618005 Alkalihalobacillus pseudofirmus (strain ATCC BAA-2126 / JCM 17055 / OF4) Uncharacterized protein BpOF4_00885 Proteins 0.000 description 2
- 102100020724 Ankyrin repeat, SAM and basic leucine zipper domain-containing protein 1 Human genes 0.000 description 2
- 101000967489 Azorhizobium caulinodans (strain ATCC 43989 / DSM 5975 / JCM 20966 / LMG 6465 / NBRC 14845 / NCIMB 13405 / ORS 571) Uncharacterized protein AZC_3924 Proteins 0.000 description 2
- 101000823761 Bacillus licheniformis Uncharacterized 9.4 kDa protein in flaL 3'region Proteins 0.000 description 2
- 101000819719 Bacillus methanolicus Uncharacterized N-acetyltransferase in lysA 3'region Proteins 0.000 description 2
- 101000789586 Bacillus subtilis (strain 168) UPF0702 transmembrane protein YkjA Proteins 0.000 description 2
- 101000792624 Bacillus subtilis (strain 168) Uncharacterized protein YbxH Proteins 0.000 description 2
- 101000790792 Bacillus subtilis (strain 168) Uncharacterized protein YckC Proteins 0.000 description 2
- 101000819705 Bacillus subtilis (strain 168) Uncharacterized protein YlxR Proteins 0.000 description 2
- 101000948218 Bacillus subtilis (strain 168) Uncharacterized protein YtxJ Proteins 0.000 description 2
- 101000718627 Bacillus thuringiensis subsp. kurstaki Putative RNA polymerase sigma-G factor Proteins 0.000 description 2
- 101710110830 Beta-agarase Proteins 0.000 description 2
- 101000641200 Bombyx mori densovirus Putative non-structural protein Proteins 0.000 description 2
- UXVMQQNJUSDDNG-UHFFFAOYSA-L Calcium chloride Chemical compound [Cl-].[Cl-].[Ca+2] UXVMQQNJUSDDNG-UHFFFAOYSA-L 0.000 description 2
- 101000947633 Claviceps purpurea Uncharacterized 13.8 kDa protein Proteins 0.000 description 2
- 108091026890 Coding region Proteins 0.000 description 2
- XFXPMWWXUTWYJX-UHFFFAOYSA-N Cyanide Chemical compound N#[C-] XFXPMWWXUTWYJX-UHFFFAOYSA-N 0.000 description 2
- 101710184973 DNA polymerase epsilon subunit 2 Proteins 0.000 description 2
- 102100029910 DNA polymerase epsilon subunit 2 Human genes 0.000 description 2
- 101710165184 DNA polymerase epsilon subunit B Proteins 0.000 description 2
- 101000948901 Enterobacteria phage T4 Uncharacterized 16.0 kDa protein in segB-ipI intergenic region Proteins 0.000 description 2
- 101000805958 Equine herpesvirus 4 (strain 1942) Virion protein US10 homolog Proteins 0.000 description 2
- 101000790442 Escherichia coli Insertion element IS2 uncharacterized 11.1 kDa protein Proteins 0.000 description 2
- 101000788354 Escherichia phage P2 Uncharacterized 8.2 kDa protein in gpA 5'region Proteins 0.000 description 2
- 241001524679 Escherichia virus M13 Species 0.000 description 2
- 108060002716 Exonuclease Proteins 0.000 description 2
- 101000770304 Frankia alni UPF0460 protein in nifX-nifW intergenic region Proteins 0.000 description 2
- 101000797344 Geobacillus stearothermophilus Putative tRNA (cytidine(34)-2'-O)-methyltransferase Proteins 0.000 description 2
- 101000748410 Geobacillus stearothermophilus Uncharacterized protein in fumA 3'region Proteins 0.000 description 2
- 101000772675 Haemophilus influenzae (strain ATCC 51907 / DSM 11121 / KW20 / Rd) UPF0438 protein HI_0847 Proteins 0.000 description 2
- 101000631019 Haemophilus influenzae (strain ATCC 51907 / DSM 11121 / KW20 / Rd) Uncharacterized protein HI_0350 Proteins 0.000 description 2
- 101000785414 Homo sapiens Ankyrin repeat, SAM and basic leucine zipper domain-containing protein 1 Proteins 0.000 description 2
- 102100034343 Integrase Human genes 0.000 description 2
- 101000782488 Junonia coenia densovirus (isolate pBRJ/1990) Putative non-structural protein NS2 Proteins 0.000 description 2
- 101000811523 Klebsiella pneumoniae Uncharacterized 55.8 kDa protein in cps region Proteins 0.000 description 2
- 101000818409 Lactococcus lactis subsp. lactis Uncharacterized HTH-type transcriptional regulator in lacX 3'region Proteins 0.000 description 2
- 101000878851 Leptolyngbya boryana Putative Fe(2+) transport protein A Proteins 0.000 description 2
- 101000758828 Methanosarcina barkeri (strain Fusaro / DSM 804) Uncharacterized protein Mbar_A1602 Proteins 0.000 description 2
- 101001122401 Middle East respiratory syndrome-related coronavirus (isolate United Kingdom/H123990006/2012) Non-structural protein ORF3 Proteins 0.000 description 2
- 241000699670 Mus sp. Species 0.000 description 2
- 101001055788 Mycolicibacterium smegmatis (strain ATCC 700084 / mc(2)155) Pentapeptide repeat protein MfpA Proteins 0.000 description 2
- 101000740670 Orgyia pseudotsugata multicapsid polyhedrosis virus Protein C42 Proteins 0.000 description 2
- 241000283973 Oryctolagus cuniculus Species 0.000 description 2
- 101000769182 Photorhabdus luminescens Uncharacterized protein in pnp 3'region Proteins 0.000 description 2
- 101000961392 Pseudescherichia vulneris Uncharacterized 29.9 kDa protein in crtE 3'region Proteins 0.000 description 2
- 101000731030 Pseudomonas oleovorans Poly(3-hydroxyalkanoate) polymerase 2 Proteins 0.000 description 2
- 101001065485 Pseudomonas putida Probable fatty acid methyltransferase Proteins 0.000 description 2
- 241000205156 Pyrococcus furiosus Species 0.000 description 2
- 102000018120 Recombinases Human genes 0.000 description 2
- 108010091086 Recombinases Proteins 0.000 description 2
- 102000018780 Replication Protein A Human genes 0.000 description 2
- 108010027643 Replication Protein A Proteins 0.000 description 2
- 101000711023 Rhizobium leguminosarum bv. trifolii Uncharacterized protein in tfuA 3'region Proteins 0.000 description 2
- 101000948156 Rhodococcus erythropolis Uncharacterized 47.3 kDa protein in thcA 5'region Proteins 0.000 description 2
- 101000917565 Rhodococcus fascians Uncharacterized 33.6 kDa protein in fasciation locus Proteins 0.000 description 2
- 101000790284 Saimiriine herpesvirus 2 (strain 488) Uncharacterized 9.5 kDa protein in DHFR 3'region Proteins 0.000 description 2
- 108020004682 Single-Stranded DNA Proteins 0.000 description 2
- 101000936719 Streptococcus gordonii Accessory Sec system protein Asp3 Proteins 0.000 description 2
- 101000788499 Streptomyces coelicolor Uncharacterized oxidoreductase in mprA 5'region Proteins 0.000 description 2
- 101001102841 Streptomyces griseus Purine nucleoside phosphorylase ORF3 Proteins 0.000 description 2
- 101000708557 Streptomyces lincolnensis Uncharacterized 17.2 kDa protein in melC2-rnhH intergenic region Proteins 0.000 description 2
- 101000649826 Thermotoga neapolitana Putative anti-sigma factor antagonist TM1081 homolog Proteins 0.000 description 2
- 101000827562 Vibrio alginolyticus Uncharacterized protein in proC 3'region Proteins 0.000 description 2
- 101000778915 Vibrio parahaemolyticus serotype O3:K6 (strain RIMD 2210633) Uncharacterized membrane protein VP2115 Proteins 0.000 description 2
- 239000011543 agarose gel Substances 0.000 description 2
- AVKUERGKIZMTKX-NJBDSQKTSA-N ampicillin Chemical compound C1([C@@H](N)C(=O)N[C@H]2[C@H]3SC([C@@H](N3C2=O)C(O)=O)(C)C)=CC=CC=C1 AVKUERGKIZMTKX-NJBDSQKTSA-N 0.000 description 2
- 229960000723 ampicillin Drugs 0.000 description 2
- 210000003578 bacterial chromosome Anatomy 0.000 description 2
- 230000001580 bacterial effect Effects 0.000 description 2
- 239000013060 biological fluid Substances 0.000 description 2
- 239000001110 calcium chloride Substances 0.000 description 2
- 235000011148 calcium chloride Nutrition 0.000 description 2
- 229910001628 calcium chloride Inorganic materials 0.000 description 2
- FPPNZSSZRUTDAP-UWFZAAFLSA-N carbenicillin Chemical compound N([C@H]1[C@H]2SC([C@@H](N2C1=O)C(O)=O)(C)C)C(=O)C(C(O)=O)C1=CC=CC=C1 FPPNZSSZRUTDAP-UWFZAAFLSA-N 0.000 description 2
- 229960003669 carbenicillin Drugs 0.000 description 2
- 150000001720 carbohydrates Chemical class 0.000 description 2
- 235000014633 carbohydrates Nutrition 0.000 description 2
- 230000000052 comparative effect Effects 0.000 description 2
- 238000010276 construction Methods 0.000 description 2
- 238000006073 displacement reaction Methods 0.000 description 2
- 238000011156 evaluation Methods 0.000 description 2
- 102000013165 exonuclease Human genes 0.000 description 2
- 238000002474 experimental method Methods 0.000 description 2
- 238000001400 expression cloning Methods 0.000 description 2
- 230000004927 fusion Effects 0.000 description 2
- 102000037865 fusion proteins Human genes 0.000 description 2
- 108020001507 fusion proteins Proteins 0.000 description 2
- 230000012010 growth Effects 0.000 description 2
- 239000001963 growth medium Substances 0.000 description 2
- 239000012456 homogeneous solution Substances 0.000 description 2
- 210000003000 inclusion body Anatomy 0.000 description 2
- 239000000411 inducer Substances 0.000 description 2
- 229910001629 magnesium chloride Inorganic materials 0.000 description 2
- 230000035800 maturation Effects 0.000 description 2
- 230000003287 optical effect Effects 0.000 description 2
- JMANVNJQNLATNU-UHFFFAOYSA-N oxalonitrile Chemical compound N#CC#N JMANVNJQNLATNU-UHFFFAOYSA-N 0.000 description 2
- LCCNCVORNKJIRZ-UHFFFAOYSA-N parathion Chemical compound CCOP(=S)(OCC)OC1=CC=C([N+]([O-])=O)C=C1 LCCNCVORNKJIRZ-UHFFFAOYSA-N 0.000 description 2
- YBYRMVIVWMBXKQ-UHFFFAOYSA-N phenylmethanesulfonyl fluoride Chemical compound FS(=O)(=O)CC1=CC=CC=C1 YBYRMVIVWMBXKQ-UHFFFAOYSA-N 0.000 description 2
- 229910000160 potassium phosphate Inorganic materials 0.000 description 2
- 235000011009 potassium phosphates Nutrition 0.000 description 2
- 238000001556 precipitation Methods 0.000 description 2
- 230000002829 reductive effect Effects 0.000 description 2
- 230000000717 retained effect Effects 0.000 description 2
- 230000002441 reversible effect Effects 0.000 description 2
- 150000008163 sugars Chemical class 0.000 description 2
- 230000002194 synthesizing effect Effects 0.000 description 2
- 210000001519 tissue Anatomy 0.000 description 2
- 229910001868 water Inorganic materials 0.000 description 2
- 108091027075 5S-rRNA precursor Proteins 0.000 description 1
- 101100542119 Acidianus filamentous virus 1 (isolate United States/Yellowstone) ORF223 gene Proteins 0.000 description 1
- 108010045149 Archaeal Proteins Proteins 0.000 description 1
- 241000205042 Archaeoglobus fulgidus Species 0.000 description 1
- 239000004475 Arginine Substances 0.000 description 1
- DCXYFEDJOCDNAF-UHFFFAOYSA-N Asparagine Natural products OC(=O)C(N)CC(N)=O DCXYFEDJOCDNAF-UHFFFAOYSA-N 0.000 description 1
- 101000631235 Borrelia burgdorferi (strain ATCC 35210 / B31 / CIP 102532 / DSM 4680) Uncharacterized protein BB_0268 Proteins 0.000 description 1
- CPELXLSAUQHCOX-UHFFFAOYSA-M Bromide Chemical compound [Br-] CPELXLSAUQHCOX-UHFFFAOYSA-M 0.000 description 1
- 101000583086 Bunodosoma granuliferum Delta-actitoxin-Bgr2b Proteins 0.000 description 1
- 102000014914 Carrier Proteins Human genes 0.000 description 1
- 108090000317 Chymotrypsin Proteins 0.000 description 1
- 241001478240 Coccus Species 0.000 description 1
- 102000029816 Collagenase Human genes 0.000 description 1
- 108060005980 Collagenase Proteins 0.000 description 1
- 241000699800 Cricetinae Species 0.000 description 1
- 102000012410 DNA Ligases Human genes 0.000 description 1
- 108010061982 DNA Ligases Proteins 0.000 description 1
- 101000624615 Dictyostelium discoideum Uncharacterized mitochondrial protein Mp36 Proteins 0.000 description 1
- 241000701959 Escherichia virus Lambda Species 0.000 description 1
- 229920002148 Gellan gum Polymers 0.000 description 1
- WHUUTDBJXJRKMK-UHFFFAOYSA-N Glutamic acid Natural products OC(=O)C(N)CCC(O)=O WHUUTDBJXJRKMK-UHFFFAOYSA-N 0.000 description 1
- 241000238631 Hexapoda Species 0.000 description 1
- 108010061833 Integrases Proteins 0.000 description 1
- DCXYFEDJOCDNAF-REOHCLBHSA-N L-asparagine Chemical compound OC(=O)[C@@H](N)CC(N)=O DCXYFEDJOCDNAF-REOHCLBHSA-N 0.000 description 1
- CKLJMWTZIZZHCS-REOHCLBHSA-N L-aspartic acid Chemical compound OC(=O)[C@@H](N)CC(O)=O CKLJMWTZIZZHCS-REOHCLBHSA-N 0.000 description 1
- AGPKZVBTJJNPAG-WHFBIAKZSA-N L-isoleucine Chemical compound CC[C@H](C)[C@H](N)C(O)=O AGPKZVBTJJNPAG-WHFBIAKZSA-N 0.000 description 1
- ROHFNLRQFUQHCH-YFKPBYRVSA-N L-leucine Chemical compound CC(C)C[C@H](N)C(O)=O ROHFNLRQFUQHCH-YFKPBYRVSA-N 0.000 description 1
- KZSNJWFQEVHDMF-BYPYZUCNSA-N L-valine Chemical compound CC(C)[C@H](N)C(O)=O KZSNJWFQEVHDMF-BYPYZUCNSA-N 0.000 description 1
- 101000787090 Lactobacillus delbrueckii subsp. bulgaricus Uncharacterized 33.9 kDa protein in glnA 5'region Proteins 0.000 description 1
- ROHFNLRQFUQHCH-UHFFFAOYSA-N Leucine Natural products CC(C)CC(N)C(O)=O ROHFNLRQFUQHCH-UHFFFAOYSA-N 0.000 description 1
- KDXKERNSBIXSRK-UHFFFAOYSA-N Lysine Natural products NCCCCC(N)C(O)=O KDXKERNSBIXSRK-UHFFFAOYSA-N 0.000 description 1
- 239000004472 Lysine Substances 0.000 description 1
- 241001529936 Murinae Species 0.000 description 1
- 101150008132 NDE1 gene Proteins 0.000 description 1
- 108010010677 Phosphodiesterase I Proteins 0.000 description 1
- 101710180319 Protease 1 Proteins 0.000 description 1
- 101100064061 Pyrococcus abyssi (strain GE5 / Orsay) polI gene Proteins 0.000 description 1
- 101100087339 Pyrococcus abyssi (strain GE5 / Orsay) rfcL gene Proteins 0.000 description 1
- 101100468506 Pyrococcus abyssi (strain GE5 / Orsay) rfcS gene Proteins 0.000 description 1
- 241000522615 Pyrococcus horikoshii Species 0.000 description 1
- 241001467519 Pyrococcus sp. Species 0.000 description 1
- 108010066717 Q beta Replicase Proteins 0.000 description 1
- 108010092799 RNA-directed DNA polymerase Proteins 0.000 description 1
- 101710151532 Replicating protein Proteins 0.000 description 1
- 241000235070 Saccharomyces Species 0.000 description 1
- 240000004808 Saccharomyces cerevisiae Species 0.000 description 1
- 238000002105 Southern blotting Methods 0.000 description 1
- 108010006785 Taq Polymerase Proteins 0.000 description 1
- 241000204969 Thermococcales Species 0.000 description 1
- 101710137710 Thioesterase 1/protease 1/lysophospholipase L1 Proteins 0.000 description 1
- 101000788530 Triticum aestivum Putative ATP synthase protein YMF19 Proteins 0.000 description 1
- 108090000631 Trypsin Proteins 0.000 description 1
- 102000004142 Trypsin Human genes 0.000 description 1
- KZSNJWFQEVHDMF-UHFFFAOYSA-N Valine Natural products CC(C)C(N)C(O)=O KZSNJWFQEVHDMF-UHFFFAOYSA-N 0.000 description 1
- 241000700605 Viruses Species 0.000 description 1
- HCHKCACWOHOZIP-UHFFFAOYSA-N Zinc Chemical compound [Zn] HCHKCACWOHOZIP-UHFFFAOYSA-N 0.000 description 1
- 230000002378 acidificating effect Effects 0.000 description 1
- 230000004913 activation Effects 0.000 description 1
- 210000004102 animal cell Anatomy 0.000 description 1
- 239000003242 anti bacterial agent Substances 0.000 description 1
- 229940088710 antibiotic agent Drugs 0.000 description 1
- 238000013459 approach Methods 0.000 description 1
- ODKSFYDXXFIFQN-UHFFFAOYSA-N arginine Natural products OC(=O)C(N)CCCNC(N)=N ODKSFYDXXFIFQN-UHFFFAOYSA-N 0.000 description 1
- 125000000637 arginyl group Chemical class N[C@@H](CCCNC(N)=N)C(=O)* 0.000 description 1
- 229960001230 asparagine Drugs 0.000 description 1
- 235000009582 asparagine Nutrition 0.000 description 1
- 235000003704 aspartic acid Nutrition 0.000 description 1
- 238000000376 autoradiography Methods 0.000 description 1
- 244000052616 bacterial pathogen Species 0.000 description 1
- OQFSQFPPLPISGP-UHFFFAOYSA-N beta-carboxyaspartic acid Natural products OC(=O)C(N)C(C(O)=O)C(O)=O OQFSQFPPLPISGP-UHFFFAOYSA-N 0.000 description 1
- 238000002306 biochemical method Methods 0.000 description 1
- 238000010804 cDNA synthesis Methods 0.000 description 1
- 244000309466 calf Species 0.000 description 1
- 230000015556 catabolic process Effects 0.000 description 1
- 230000010261 cell growth Effects 0.000 description 1
- 230000008859 change Effects 0.000 description 1
- 229960002376 chymotrypsin Drugs 0.000 description 1
- 238000005352 clarification Methods 0.000 description 1
- 238000003776 cleavage reaction Methods 0.000 description 1
- 229960002424 collagenase Drugs 0.000 description 1
- 238000010835 comparative analysis Methods 0.000 description 1
- 239000002299 complementary DNA Substances 0.000 description 1
- 238000012937 correction Methods 0.000 description 1
- 239000013601 cosmid vector Substances 0.000 description 1
- 238000012272 crop production Methods 0.000 description 1
- 239000013078 crystal Substances 0.000 description 1
- 238000002425 crystallisation Methods 0.000 description 1
- 230000008025 crystallization Effects 0.000 description 1
- 125000004093 cyano group Chemical group *C#N 0.000 description 1
- ATDGTVJJHBUTRL-UHFFFAOYSA-N cyanogen bromide Chemical compound BrC#N ATDGTVJJHBUTRL-UHFFFAOYSA-N 0.000 description 1
- 230000001351 cycling effect Effects 0.000 description 1
- 238000000354 decomposition reaction Methods 0.000 description 1
- 230000003247 decreasing effect Effects 0.000 description 1
- 230000007812 deficiency Effects 0.000 description 1
- 238000006731 degradation reaction Methods 0.000 description 1
- 239000008367 deionised water Substances 0.000 description 1
- 229910021641 deionized water Inorganic materials 0.000 description 1
- 238000011161 development Methods 0.000 description 1
- 230000018109 developmental process Effects 0.000 description 1
- 239000012502 diagnostic product Substances 0.000 description 1
- 238000010586 diagram Methods 0.000 description 1
- 238000002635 electroconvulsive therapy Methods 0.000 description 1
- 238000004520 electroporation Methods 0.000 description 1
- 230000009088 enzymatic function Effects 0.000 description 1
- 238000012869 ethanol precipitation Methods 0.000 description 1
- 210000003527 eukaryotic cell Anatomy 0.000 description 1
- 230000007717 exclusion Effects 0.000 description 1
- 230000001605 fetal effect Effects 0.000 description 1
- 238000007730 finishing process Methods 0.000 description 1
- 238000005194 fractionation Methods 0.000 description 1
- 210000004602 germ cell Anatomy 0.000 description 1
- 235000013922 glutamic acid Nutrition 0.000 description 1
- 239000004220 glutamic acid Substances 0.000 description 1
- ZDXPYRJPNDTMRX-UHFFFAOYSA-N glutamine Natural products OC(=O)C(N)CCC(N)=O ZDXPYRJPNDTMRX-UHFFFAOYSA-N 0.000 description 1
- 238000000265 homogenisation Methods 0.000 description 1
- 238000002744 homologous recombination Methods 0.000 description 1
- 230000006801 homologous recombination Effects 0.000 description 1
- 230000002209 hydrophobic effect Effects 0.000 description 1
- 230000014726 immortalization of host cell Effects 0.000 description 1
- 238000011534 incubation Methods 0.000 description 1
- 230000001939 inductive effect Effects 0.000 description 1
- 208000015181 infectious disease Diseases 0.000 description 1
- 238000004255 ion exchange chromatography Methods 0.000 description 1
- 150000002500 ions Chemical class 0.000 description 1
- 238000002955 isolation Methods 0.000 description 1
- 229960000310 isoleucine Drugs 0.000 description 1
- AGPKZVBTJJNPAG-UHFFFAOYSA-N isoleucine Natural products CCC(C)C(N)C(O)=O AGPKZVBTJJNPAG-UHFFFAOYSA-N 0.000 description 1
- 238000005304 joining Methods 0.000 description 1
- 125000000400 lauroyl group Chemical group O=C([*])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])[H] 0.000 description 1
- 239000003446 ligand Substances 0.000 description 1
- 238000001638 lipofection Methods 0.000 description 1
- 239000002502 liposome Substances 0.000 description 1
- 230000004807 localization Effects 0.000 description 1
- 238000000464 low-speed centrifugation Methods 0.000 description 1
- 210000004962 mammalian cell Anatomy 0.000 description 1
- 210000001161 mammalian embryo Anatomy 0.000 description 1
- FQXKZRWLIJVZPF-UHFFFAOYSA-N marsin Natural products OC1C(O)C(O)C(C)OC1OC1CC2=CCC3C4(O)CCC(C(C)=O)C4(C)CCC3C2(C)CC1 FQXKZRWLIJVZPF-UHFFFAOYSA-N 0.000 description 1
- 230000001404 mediated effect Effects 0.000 description 1
- 230000009456 molecular mechanism Effects 0.000 description 1
- 238000002703 mutagenesis Methods 0.000 description 1
- 231100000350 mutagenesis Toxicity 0.000 description 1
- LWGJTAZLEJHCPA-UHFFFAOYSA-N n-(2-chloroethyl)-n-nitrosomorpholine-4-carboxamide Chemical compound ClCCN(N=O)C(=O)N1CCOCC1 LWGJTAZLEJHCPA-UHFFFAOYSA-N 0.000 description 1
- 229940124276 oligodeoxyribonucleotide Drugs 0.000 description 1
- 210000001672 ovary Anatomy 0.000 description 1
- 230000002018 overexpression Effects 0.000 description 1
- 230000003647 oxidation Effects 0.000 description 1
- 238000007254 oxidation reaction Methods 0.000 description 1
- 230000001590 oxidative effect Effects 0.000 description 1
- 238000004806 packaging method and process Methods 0.000 description 1
- 244000045947 parasite Species 0.000 description 1
- 239000008188 pellet Substances 0.000 description 1
- 238000010647 peptide synthesis reaction Methods 0.000 description 1
- 230000002085 persistent effect Effects 0.000 description 1
- 239000013600 plasmid vector Substances 0.000 description 1
- 238000002264 polyacrylamide gel electrophoresis Methods 0.000 description 1
- 102000054765 polymorphisms of proteins Human genes 0.000 description 1
- 230000004481 post-translational protein modification Effects 0.000 description 1
- 230000001376 precipitating effect Effects 0.000 description 1
- 210000001236 prokaryotic cell Anatomy 0.000 description 1
- 230000017854 proteolysis Effects 0.000 description 1
- 229940024999 proteolytic enzymes for treatment of wounds and ulcers Drugs 0.000 description 1
- 238000011084 recovery Methods 0.000 description 1
- 230000009467 reduction Effects 0.000 description 1
- 230000008929 regeneration Effects 0.000 description 1
- 238000011069 regeneration method Methods 0.000 description 1
- 230000001105 regulatory effect Effects 0.000 description 1
- 238000012958 reprocessing Methods 0.000 description 1
- 210000003705 ribosome Anatomy 0.000 description 1
- 238000005096 rolling process Methods 0.000 description 1
- 230000007017 scission Effects 0.000 description 1
- 238000000926 separation method Methods 0.000 description 1
- 239000013605 shuttle vector Substances 0.000 description 1
- 239000001509 sodium citrate Substances 0.000 description 1
- NLJMYIDDQXHKNR-UHFFFAOYSA-K sodium citrate Chemical compound O.O.[Na+].[Na+].[Na+].[O-]C(=O)CC(O)(CC([O-])=O)C([O-])=O NLJMYIDDQXHKNR-UHFFFAOYSA-K 0.000 description 1
- CIJQGPVMMRXSQW-UHFFFAOYSA-M sodium;2-aminoacetic acid;hydroxide Chemical compound O.[Na+].NCC([O-])=O CIJQGPVMMRXSQW-UHFFFAOYSA-M 0.000 description 1
- 239000007787 solid Substances 0.000 description 1
- 239000007790 solid phase Substances 0.000 description 1
- 239000002904 solvent Substances 0.000 description 1
- 230000007480 spreading Effects 0.000 description 1
- 238000003892 spreading Methods 0.000 description 1
- 230000006641 stabilisation Effects 0.000 description 1
- 238000011105 stabilization Methods 0.000 description 1
- 238000013179 statistical model Methods 0.000 description 1
- 239000008223 sterile water Substances 0.000 description 1
- 239000000126 substance Substances 0.000 description 1
- 239000006228 supernatant Substances 0.000 description 1
- 230000001225 therapeutic effect Effects 0.000 description 1
- 150000003568 thioethers Chemical class 0.000 description 1
- 210000001541 thymus gland Anatomy 0.000 description 1
- 238000012546 transfer Methods 0.000 description 1
- 238000005829 trimerization reaction Methods 0.000 description 1
- GPRLSGONYQIRFK-MNYXATJNSA-N triton Chemical compound [3H+] GPRLSGONYQIRFK-MNYXATJNSA-N 0.000 description 1
- 239000012588 trypsin Substances 0.000 description 1
- 229960001322 trypsin Drugs 0.000 description 1
- 241000701447 unidentified baculovirus Species 0.000 description 1
- 239000004474 valine Substances 0.000 description 1
- 238000012800 visualization Methods 0.000 description 1
- 210000005253 yeast cell Anatomy 0.000 description 1
- 239000011701 zinc Substances 0.000 description 1
- 229910052725 zinc Inorganic materials 0.000 description 1
Images
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/195—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
-
- A—HUMAN NECESSITIES
- A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
- A01K—ANIMAL HUSBANDRY; AVICULTURE; APICULTURE; PISCICULTURE; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
- A01K2217/00—Genetically modified animals
- A01K2217/05—Animals comprising random inserted nucleic acids (transgenic)
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Biophysics (AREA)
- General Health & Medical Sciences (AREA)
- Genetics & Genomics (AREA)
- Life Sciences & Earth Sciences (AREA)
- Molecular Biology (AREA)
- Biochemistry (AREA)
- Gastroenterology & Hepatology (AREA)
- Peptides Or Proteins (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Enzymes And Modification Thereof (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| FR9905034A FR2792651B1 (fr) | 1999-04-21 | 1999-04-21 | Sequence genomique et polypeptides de pyrococcus abyssi, leurs fragments et leurs utilisations |
| PCT/FR2000/001065 WO2000065062A2 (fr) | 1999-04-21 | 2000-04-21 | Sequence genomique et polypeptides de pyrococcus abissy, leurs fragments et leurs utilisations |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2004500802A true JP2004500802A (ja) | 2004-01-15 |
| JP2004500802A5 JP2004500802A5 (enExample) | 2005-07-21 |
Family
ID=9544691
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2000614397A Pending JP2004500802A (ja) | 1999-04-21 | 2000-04-21 | ピロコッカス・アビシのゲノム配列およびポリペプチド、そのフラグメントおよびその使用 |
Country Status (8)
| Country | Link |
|---|---|
| EP (1) | EP1196583B1 (enExample) |
| JP (1) | JP2004500802A (enExample) |
| AT (1) | ATE332971T1 (enExample) |
| AU (1) | AU4302000A (enExample) |
| CA (1) | CA2371253A1 (enExample) |
| DE (1) | DE60029325T2 (enExample) |
| FR (1) | FR2792651B1 (enExample) |
| WO (1) | WO2000065062A2 (enExample) |
Families Citing this family (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CA2602183C (en) | 2005-03-18 | 2014-05-06 | Microbia, Inc. | Production of carotenoids in oleaginous yeast and fungi |
| EP2078092A2 (en) | 2006-09-28 | 2009-07-15 | Microbia, Inc. | Production of carotenoids in oleaginous yeast and fungi |
| US11829886B2 (en) | 2018-03-07 | 2023-11-28 | International Business Machines Corporation | Epistemic and aleatoric deep plasticity based on sound feedback |
| GB201918108D0 (en) * | 2019-12-10 | 2020-01-22 | Vib Vzw | Improved aminopeptiadases for single molecule peptide sequencing |
| WO2021163559A1 (en) * | 2020-02-13 | 2021-08-19 | New England Biolabs, Inc. | Variant family d dna polymerases |
| EP4103701A1 (en) * | 2020-02-13 | 2022-12-21 | New England Biolabs, Inc. | Variant family d dna polymerases |
| WO2024006783A2 (en) * | 2022-06-30 | 2024-01-04 | Illumina, Inc. | Methylation detection with a non-natural/unnatural base |
Citations (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO1997024444A1 (en) * | 1995-12-27 | 1997-07-10 | Takara Shuzo Co., Ltd. | Novel dna polymerase |
| WO1998001567A2 (fr) * | 1996-07-10 | 1998-01-15 | Appligene-Oncor S.A. | ADN POLYMERASE THERMOSTABLE D'ARCHAEBACTERIES DU GENRE $i(PYROCOCCUS SP.) |
Family Cites Families (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP0997530B1 (en) * | 1997-06-26 | 2006-08-23 | Takara Bio Inc. | Dna polymerase-related factors |
| WO2000008164A2 (de) * | 1998-08-06 | 2000-02-17 | Lion Bioscience Ag | Thermostabiler in vitro-komplex mit polymeraseaktivität |
-
1999
- 1999-04-21 FR FR9905034A patent/FR2792651B1/fr not_active Expired - Fee Related
-
2000
- 2000-04-21 JP JP2000614397A patent/JP2004500802A/ja active Pending
- 2000-04-21 WO PCT/FR2000/001065 patent/WO2000065062A2/fr not_active Ceased
- 2000-04-21 AU AU43020/00A patent/AU4302000A/en not_active Abandoned
- 2000-04-21 DE DE60029325T patent/DE60029325T2/de not_active Expired - Lifetime
- 2000-04-21 CA CA002371253A patent/CA2371253A1/fr not_active Abandoned
- 2000-04-21 AT AT00922717T patent/ATE332971T1/de not_active IP Right Cessation
- 2000-04-21 EP EP00922717A patent/EP1196583B1/fr not_active Expired - Lifetime
Patent Citations (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO1997024444A1 (en) * | 1995-12-27 | 1997-07-10 | Takara Shuzo Co., Ltd. | Novel dna polymerase |
| WO1998001567A2 (fr) * | 1996-07-10 | 1998-01-15 | Appligene-Oncor S.A. | ADN POLYMERASE THERMOSTABLE D'ARCHAEBACTERIES DU GENRE $i(PYROCOCCUS SP.) |
Also Published As
| Publication number | Publication date |
|---|---|
| ATE332971T1 (de) | 2006-08-15 |
| EP1196583A2 (fr) | 2002-04-17 |
| FR2792651A1 (fr) | 2000-10-27 |
| CA2371253A1 (fr) | 2000-11-02 |
| DE60029325D1 (en) | 2006-08-24 |
| EP1196583B1 (fr) | 2006-07-12 |
| WO2000065062A2 (fr) | 2000-11-02 |
| WO2000065062A9 (fr) | 2002-09-06 |
| DE60029325T2 (de) | 2007-03-08 |
| WO2000065062A3 (fr) | 2002-02-14 |
| AU4302000A (en) | 2000-11-10 |
| FR2792651B1 (fr) | 2005-03-18 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| KR102894634B1 (ko) | 세포 또는 유기체의 게놈으로의 ＤＮＡ 서열의 표적화 혼입을 위한 Ｃａｓ 9 레트로바이러스 인테그라제 시스템 및 Ｃａｓ 9 재조합효소 시스템 | |
| US7670807B2 (en) | RNA-dependent DNA polymerase from Geobacillus stearothermophilus | |
| JP3761197B2 (ja) | 新規ｄｎａポリメラーゼ | |
| KR101420991B1 (ko) | 테르펜 합성효소 변이체들을 개발하는 방법들 | |
| CN115916980A (zh) | 生产天冬氨酸和甲硫氨酸的嗜氢菌属细菌的转化体 | |
| CN101880681B (zh) | 麦芽寡糖基海藻糖水解酶基因序列及其重组蛋白制备方法 | |
| JP2002538789A5 (enExample) | ||
| JPH05328969A (ja) | Ｐｙｒｏｃｏｃｃｕｓ種から得られる精製耐熱性ＤＮＡポリメラーゼ | |
| JP2004500802A (ja) | ピロコッカス・アビシのゲノム配列およびポリペプチド、そのフラグメントおよびその使用 | |
| JP2010263880A (ja) | 微生物由来の新規コラゲナーゼ遺伝子 | |
| ES2313725T3 (es) | Nuevas moleculas de adn. | |
| JPH08196281A (ja) | 水生成型ｎａｄｈオキシダーゼをコードするｄｎａ | |
| JP2004535802A (ja) | 新規なインテイン及びその使用 | |
| RU2453599C1 (ru) | НУКЛЕИНОВАЯ КИСЛОТА, КОДИРУЮЩАЯ ФУНКЦИОНАЛЬНО АКТИВНУЮ РЕКОМБИНАНТНУЮ IgA1 ПРОТЕАЗУ NEISSERIA MENINGITIDIS СЕРОГРУППЫ B, РЕКОМБИНАНТНАЯ ПЛАЗМИДНАЯ ДНК, СОДЕРЖАЩАЯ НУКЛЕОТИДНУЮ ПОСЛЕДОВАТЕЛЬНОСТЬ, КОДИРУЮЩУЮ АКТИВНУЮ IgA1 ПРОТЕАЗУ, ШТАММ-ПРОДУЦЕНТ, СОДЕРЖАЩИЙ ПЛАЗМИДНУЮ ДНК, ПРОДУЦИРУЮЩИЙ ЗРЕЛУЮ ФОРМУ IgA1 ПРОТЕАЗЫ, РЕКОМБИНАНТНАЯ Ig ПРОТЕАЗА NEISSERIA MENINGITIDIS СЕРОГРУППЫ В, СПОСОБ ПОЛУЧЕНИЯ ЗРЕЛОЙ ФОРМЫ IgA1 ПРОТЕАЗЫ, ОБЛАДАЮЩЕЙ ИММУНОГЕННЫМИ И ПРОТЕКТИВНЫМИ СВОЙСТВАМИ | |
| US20110020896A1 (en) | Mutant dna polymerases and their genes | |
| RU2486243C1 (ru) | ПОЛИНУКЛЕОТИД, КОДИРУЮЩИЙ МУТАНТНУЮ РЕКОМБИНАНТНУЮ IgA1 ПРОТЕАЗУ Neisseria meningitidis СЕРОГРУППЫ В, РЕКОМБИНАНТНАЯ ПЛАЗМИДНАЯ ДНК, СОДЕРЖАЩАЯ УКАЗАННЫЙ ПОЛИНУКЛЕОТИД, КЛЕТКА-ХОЗЯИН, СОДЕРЖАЩАЯ УКАЗАННУЮ ПЛАЗМИДНУЮ ДНК, РЕКОМБИНАНТНАЯ IgA1 ПРОТЕАЗА Neisseria memingitidis СЕРОГРУППЫ В, СПОСОБ ПОЛУЧЕНИЯ ЗРЕЛОЙ ФОРМЫ IgA1 ПРОТЕАЗЫ | |
| JPH1175849A (ja) | パイロコッカス属に属する超好熱性細菌由来の耐熱性Ｆｌａｐエンドヌクレアーゼ | |
| JP3498808B2 (ja) | Ｄｎａポリメラーゼ遺伝子 | |
| JP2002360259A (ja) | Ｓｈｅｗａｎｅｌｌａｓｐ．ＳＩＢ１株由来の新規なアルカリフォスファターゼ | |
| WO1996012798A1 (en) | Purified thermostable inorganic pyrophosphatase obtainable from thermococcus litoralis | |
| JP3463951B2 (ja) | 耐熱性ピログルタミルペプチダーゼ及びその遺伝子 | |
| KR100861585B1 (ko) | 피크로필러스 토리두스 유래의 내열성 피로포스파타제 | |
| JP3373249B2 (ja) | 熱ショック蛋白質遺伝子および熱ショック蛋白質の製造方法 | |
| WO2004020621A1 (ja) | 耐熱性リボヌクレアーゼh | |
| JP4714848B2 (ja) | Ｄｎａポリメラーゼ変異体 |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| A621 | Written request for application examination |
Free format text: JAPANESE INTERMEDIATE CODE: A621 Effective date: 20070104 |
|
| A711 | Notification of change in applicant |
Free format text: JAPANESE INTERMEDIATE CODE: A711 Effective date: 20070625 |
|
| A521 | Request for written amendment filed |
Free format text: JAPANESE INTERMEDIATE CODE: A821 Effective date: 20070625 |
|
| A521 | Request for written amendment filed |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20070806 |
|
| A521 | Request for written amendment filed |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20070806 |
|
| A131 | Notification of reasons for refusal |
Free format text: JAPANESE INTERMEDIATE CODE: A131 Effective date: 20100105 |
|
| A601 | Written request for extension of time |
Free format text: JAPANESE INTERMEDIATE CODE: A601 Effective date: 20100402 |
|
| A602 | Written permission of extension of time |
Free format text: JAPANESE INTERMEDIATE CODE: A602 Effective date: 20100409 |
|
| A601 | Written request for extension of time |
Free format text: JAPANESE INTERMEDIATE CODE: A601 Effective date: 20100430 |
|
| A602 | Written permission of extension of time |
Free format text: JAPANESE INTERMEDIATE CODE: A602 Effective date: 20100512 |
|
| A601 | Written request for extension of time |
Free format text: JAPANESE INTERMEDIATE CODE: A601 Effective date: 20100603 |
|
| A602 | Written permission of extension of time |
Free format text: JAPANESE INTERMEDIATE CODE: A602 Effective date: 20100610 |
|
| A521 | Request for written amendment filed |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20100705 |
|
| A131 | Notification of reasons for refusal |
Free format text: JAPANESE INTERMEDIATE CODE: A131 Effective date: 20101102 |
|
| A601 | Written request for extension of time |
Free format text: JAPANESE INTERMEDIATE CODE: A601 Effective date: 20110128 |
|
| A602 | Written permission of extension of time |
Free format text: JAPANESE INTERMEDIATE CODE: A602 Effective date: 20110204 |
|
| A601 | Written request for extension of time |
Free format text: JAPANESE INTERMEDIATE CODE: A601 Effective date: 20110301 |
|
| A602 | Written permission of extension of time |
Free format text: JAPANESE INTERMEDIATE CODE: A602 Effective date: 20110308 |
|
| A601 | Written request for extension of time |
Free format text: JAPANESE INTERMEDIATE CODE: A601 Effective date: 20110401 |
|
| A602 | Written permission of extension of time |
Free format text: JAPANESE INTERMEDIATE CODE: A602 Effective date: 20110408 |
|
| A521 | Request for written amendment filed |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20110428 |
|
| A02 | Decision of refusal |
Free format text: JAPANESE INTERMEDIATE CODE: A02 Effective date: 20120124 |